Clinical Trial Update: Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney Donation

View source ↗

Summary

This completed clinical trial from Istanbul University evaluated cardiovascular and renal outcomes after reducing renal mass via living kidney donation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albuminuria
• Chronic Kidney Disease
• End-stage Renal Disease
• Hypertension

Snippet

Sponsor: Istanbul University | Conditions: Kidney Failure, Hypertension | Status: COMPLETED